Who this arrangement is actually built for
Let's concede the obvious upfront. If your situation is simple, your records are clean, and all you want is a signature, a nearby storefront will get you there faster, and we won't pretend otherwise. The St. Petersburg patients who choose us tend to be a different group, and they usually recognize themselves in one of three descriptions.
The first is medication complexity. Someone taking blood thinners, seizure medication, psychiatric prescriptions, or a long list of anything needs an interaction conversation before adding cannabis, and that conversation doesn't fit in fifteen minutes. The second is chronic disease that's being managed, not just documented. When the qualifying condition is Crohn's, Parkinson's, MS, or pain from a degenerative process, cannabis is one variable inside an ongoing treatment plan, and it helps when the certifying physician actually practices chronic disease management. The third is PTSD and the mental health picture around it. Ascend runs psychiatry and talk therapy inside the same practice, so a PTSD certification can sit next to actual trauma care instead of floating alone.
If none of that describes you, we're genuinely fine being the option you didn't need. If one of them does, keep reading.
One visit in the room, then a video rhythm
Here's the structural fact that makes the arrangement workable: in most cases you only sit in the office once. Florida law requires the initial Compassionate Use Registry evaluation to be conducted in person, with no exceptions and no legitimate online workaround. Every renewal after that is a different story. The state's required follow-up interval is currently 210 days, and Florida law allows most of those renewal visits to happen by telehealth, provided you're physically in Florida during the appointment.
For a St. Petersburg patient, that changes the calculation that would otherwise favor the storefront around the corner. The convenience of a nearby counter is collected exactly once, at the initial visit. The physician relationship, meanwhile, lasts as long as the card does, renewal after renewal, year after year. Choosing the certifying physician on proximity alone means optimizing the one part of the process that never repeats.
So the practical shape of care looks like this: one unhurried in-person evaluation, and then video renewals from your home in the Old Northeast, Gulfport, Pinellas Park, or wherever in the 337 ZIP codes you happen to live. A phone or laptop with a camera covers the technical requirements, and our care coordinator preps you before the first video visit.
One honest caveat belongs here. Telehealth covers most renewals, not all of them. If your clinical picture changes significantly, if new medications raise interaction questions, or if the physician judges that an in-person exam is needed to do the renewal responsibly, you may be asked to come in. We treat that as the exception, and we'll tell you why if it applies to you, but we won't promise a forever-remote arrangement that the medicine might not support.
What happens in the exam room at Carrollwood
The evaluation runs 30 to 45 minutes at 3971 Moran Road, Suite 101, Tampa, FL 33618. Dr. Saylor is an osteopathic family medicine physician, board certified, with 17 years in practice and the Chief Medical Officer role at Ascend, and he treats this appointment as medicine rather than paperwork. Expect a real history: the qualifying condition and its documentation, prior treatments and how they went, your full medication list, and what you're hoping cannabis will do for your symptoms.
Expect pushback where pushback is warranted, too. Cannabis isn't a first-line therapy for any condition, so the visit examines what standard care you've already tried and whether anything obvious has been skipped. A pain condition that's never had a proper workup, or trauma symptoms that have never seen a psychiatric evaluation, will get named. Inside Ascend that's not a dead end; the psychiatry and talk therapy teams are part of the same practice, and coordination between them is routine.
When the statute's requirements are met and cannabis is clinically reasonable, the recommendation goes into the Compassionate Use Registry during that same appointment. When they're not, you'll hear that directly, along with what's missing and what your alternatives look like. A physician who can't say no isn't evaluating anything.
Preparation makes the visit better, so here's what to gather beforehand. Pull whatever documents the qualifying condition: specialist consultation notes, imaging reports, hospital discharge summaries, prior medication trials and how they ended. Write out your current medication list with doses, including supplements, since interaction screening is only as good as the list it starts from. And come with your own questions written down. The appointment has room for them, which is most of the point of booking a full evaluation instead of a fast one.
The conditions Florida recognizes
Section 381.986 of the Florida Statutes carries the qualifying list. At the time of this writing it includes cancer, epilepsy, glaucoma, HIV/AIDS, post-traumatic stress disorder, ALS, Crohn's disease, Parkinson's disease, multiple sclerosis, terminal conditions diagnosed by a second physician, chronic nonmalignant pain that's caused by or originates from a qualifying condition, and medical conditions of the same kind or class as those listed. Statutes get amended, so eligibility is confirmed against current law at your visit, not against this paragraph.
Two clarifications save people wasted trips. Chronic pain qualifies only through its connection to a qualifying condition; the statute demands that documented link, and "my back hurts" without an underlying diagnosis doesn't reach it. And PTSD requires a formal, documented diagnosis, not self-identification. If you have the symptoms but not the workup, the right sequence is evaluation first, and our psychiatric team handles those. For the specialist conditions on the list, records carry the weight: bring neurology notes for MS or Parkinson's, GI documentation for Crohn's, oncology records for cancer-related symptoms. The "same kind or class" language, for what it's worth, is a physician's case-by-case judgment and not the loophole some advertising suggests.
Cancer deserves its own sentence or two, since symptom relief during treatment is one of the better-supported uses. Certification there gets coordinated with the oncology team rather than run around it, because timing against chemotherapy cycles and other medications matters. Terminal conditions follow a specific statutory mechanic as well: the diagnosis must come from a physician other than the one certifying, which is a safeguard we think the law got right.
The evidence, without the sales pitch
Some of what patients believe about cannabis is supported. A lot of it isn't, and you deserve to know which is which before you spend money on a card. The National Academies of Sciences reviewed the research in its 2017 consensus report and found substantial evidence for cannabis or cannabinoids in adult chronic pain and in chemotherapy-induced nausea and vomiting, along with moderate evidence for MS-related spasticity. Beyond those, the report found limited or insufficient evidence for most advertised uses, and it flagged how thin long-term outcome data is overall. On PTSD specifically, the literature remains mixed, which is uncomfortable given how often PTSD anchors certifications, and we say so anyway.
Federally, cannabis sits in Schedule I, and the FDA has approved no smoked or raw cannabis product for any condition. The lone FDA-approved cannabis-derived prescription drug is a purified CBD formulation for certain rare seizure disorders, and it's a pharmaceutical, not a dispensary product. Responses differ from person to person, side effects and drug interactions are real, and no honest clinic can guarantee approval or benefit. Anyone promising otherwise is telling you about their business model, not the evidence.
What the card can't shield you from
The legal ledger has a debit side, and it deserves the same plain treatment as the medical one. A Florida card offers no protection at a roadside stop; operating a vehicle while impaired by cannabis is illegal with or without a registry entry, and the card is not a defense. Federal firearm law is stricter still: under 18 U.S.C. § 922(g)(3), a user of a controlled substance can't lawfully buy or possess a firearm, and Form 4473 asks about marijuana use without caring what state you're in. Employers keep their leverage as well. Florida's law doesn't force any employer to accommodate medical cannabis, and a positive drug test can still cost you a job, particularly in federally regulated or safety-sensitive work. Add the smaller print: no home cultivation in Florida, no recognition on federal property, and no automatic reciprocity in a state that does not honor it.
We walk through all of this at the evaluation because a decision this personal should be made with the tradeoffs visible. These evaluations are for adults 18 and older. Nothing on this page is legal advice; it's information to bring to your own decision.
Two fees, two recipients, no bundled teaser
The cost structure has two parts, and conflating them is a storefront specialty. Part one is the clinical evaluation fee, paid to the practice; call (813) 670-3331 and our medical billing team will confirm current rates for the evaluation, follow-up, and renewal visit types before you commit to anything. Part two is the state's ID card application fee, paid directly to the OMMU when you apply online after your registry entry. We never touch that one.
Expect the clinical visit to be self-pay. Insurers generally won't reimburse services connected to a federally illegal Schedule I substance regardless of Florida's program, which is why most plans exclude certification visits entirely. Where a legitimate clinical scope exists, we can sometimes bill insurance for the underlying chronic disease management encounter, a chronic pain or PTSD evaluation for example, kept separate from the certification itself. HSA and FSA holders should check their plan documents before assuming those funds apply; cannabis-related exclusions are common for the same federal reasons.
The side effects nobody puts on a banner
Certification advertising describes benefits. A medical appointment has to describe the other column too, because the effects that send people back to a physician are rarely the ones they were warned about.
The common short-term effects are dose-related and mostly predictable: dry mouth, red eyes, increased appetite, a faster heart rate, dizziness or lightheadedness on standing, and impaired short-term memory, coordination, and reaction time for several hours. Anxiety and paranoia are not rare, which surprises patients who came looking for anxiety relief, and they tend to track with higher-potency products. Some people are drowsy the next morning rather than only during use.
The effects worth an actual call are different. Chest pain or palpitations, fainting, an anxiety or panic reaction that does not settle, confusion or disorientation that lasts beyond the expected window, new or worsening paranoia or unusual thinking, and severe cycles of vomiting with abdominal pain all warrant contacting us, or emergency care if the symptom is acute. That last one has a name in the literature and gets missed often because patients do not connect it to something they believe is helping.
Edible products deserve their own paragraph, because they cause a disproportionate share of bad experiences. Onset is slow and unpredictable, which invites a second dose before the first has arrived, and the resulting overshoot is the single most common reason an otherwise reasonable patient ends up in an emergency department. Storage matters for the same reason. A product that looks like food will eventually be treated like food by a child or a visitor.
None of this is an argument against certification. It is the information that separates a treatment from a purchase, and it is the part of the conversation a fifteen-minute visit does not have room for. After your evaluation the administrative side finishes from home: you file the OMMU application, pay the state its fee directly, and the identification card typically arrives within a few weeks.
Certification clinics close, and patients find out late
One pattern shows up repeatedly in St. Petersburg intake conversations: a patient was certified two or three years ago by a clinic that no longer exists, or that exists but has never contacted them again. They are not sure whether their certification is current. They are not sure who holds their records. They found out something was wrong at a dispensary rather than from a physician.
That is a predictable consequence of a business model built around a single transaction. When the revenue is at the front door, nothing about the operation is organized around the visit 210 days later, and when the economics stop working the practice closes with the follow-up obligations still outstanding.
Coming back into a family medicine practice fixes the structural problem rather than just the immediate one. The certification lives in a chart alongside the rest of your care, the renewal interval is tracked by someone whose job includes tracking it, and the practice's continued existence does not depend on a steady supply of new certifications.
Interactions, and what to tell us between visits
Interaction screening is the concrete thing a full evaluation does that a signature cannot, and it is why the medication list matters more than almost anything else you bring. Cannabinoids are handled by the same liver enzyme systems that process a large share of ordinary prescriptions, which means the arrow can point in either direction: cannabis changing the level of another medication, or another medication changing the level of the cannabis.
The categories that come up most often are sedatives and sleep medications, opioid pain medications, and muscle relaxants, where the risk is additive sedation and impaired breathing rather than anything exotic. Anticoagulants matter because levels can shift and the consequence of a shift is bleeding. Several antiseizure and psychiatric medications have documented interactions that can run either way. Blood pressure medications can combine with the drop in standing blood pressure that cannabis sometimes produces, which is how a fall happens. Alcohol amplifies most of it.
This is also the reason we ask about supplements and over-the-counter products, which patients routinely omit because they do not think of them as medications. Anything that makes you sleepy belongs on the list.
Between visits, a short list of changes is worth telling us about rather than waiting 210 days. Any new prescription from any prescriber, particularly anything sedating or anything for mood, sleep, or seizures. A hospitalization or an emergency department visit. A new diagnosis, especially a cardiac or psychiatric one. Pregnancy, or planning one. A fall, a new confusion, or a change in memory that someone at home has noticed. And the plain finding that it is not working, which is useful information rather than an admission of anything.
Telling your other physicians is the other half of this, and it is the half most often skipped. A certification your cardiologist or your psychiatrist does not know about is a blind spot in your own chart, and it surfaces at the worst possible moment, usually the first time somebody is checking exactly the interactions described above. With your authorization we will send a note; without it, please tell them yourself.
Nearby pages and related services
- The medical marijuana program: the program page for the whole practice
- Clearwater certification: the same arrangement from north Pinellas
- Tampa certification: the Hillsborough side of the bay
- Primary care: worth combining with the certification visit
- The Tampa-Carrollwood office: hours and what else happens there
- PTSD: what a formal diagnosis requires
FAQs about medical marijuana evaluation in St. Petersburg
What are Florida's qualifying conditions?
Florida law lists specific qualifying conditions, including cancer, epilepsy, glaucoma, HIV/AIDS, PTSD, ALS, Crohn's disease, Parkinson's disease, multiple sclerosis, medical conditions of the same kind or class, terminal conditions, and chronic nonmalignant pain caused by or originating from a qualifying medical condition. The list can change as state law evolves; we confirm eligibility at your evaluation based on current statute.
Where is the St. Petersburg evaluation done?
The initial Compassionate Use Registry evaluation is done in-person per Florida law at our Tampa-Carrollwood office (3971 Moran Road, Suite 101, Tampa, FL 33618). Ascend has no office in St. Petersburg. Follow-up visits can often be done via telehealth.
I was certified somewhere else. Can I move to Ascend?
Yes, and a meaningful share of our St. Petersburg patients come that way, usually after a certifying clinic closed, stopped following up, or simply never did anything beyond the first visit. Practically it means an evaluation with us so the clinical reasoning is ours to stand behind rather than inherited.
What do you need from the clinic that certified me before?
Whatever documents the qualifying condition and whatever they recorded about your certification history. If that clinic is gone, which happens more often in this category than in most of medicine, bring the underlying medical records instead. The condition is the thing that has to be established; the prior certification is context rather than proof.
Does switching restart anything?
Your registration status with the state is held by the Office of Medical Marijuana Use rather than by any clinic, so it does not simply transfer or reset because you changed physicians. Where exactly you stand depends on your current registration and the timing of your last evaluation, which we confirm at the visit rather than guessing at from a website.
Is an in-person first visit really necessary?
Yes. Florida does not permit an initial certification by video, so an in-person evaluation is unavoidable wherever you go. Whether it should be this particular practice is a fair question, and the honest answer is that it depends on what you want from it. If you want a registry entry and nothing else, there are closer options. If you want a physician who will read your records, screen your medication list for interactions, and be willing to say no, that is what a fuller appointment is buying.
Can I combine the visit with other care that day?
Often, yes, and it is worth asking. The Carrollwood office handles primary care and other services beyond certification, so if you have been meaning to establish care or address something else, mention it when you schedule and we can look at whether it fits the same appointment.
After this, how much of it can be done from home?
Most of the ongoing part. Renewal evaluations can often be handled by telehealth provided you are physically in Florida for the appointment, and the state ID card application is something you file with the Office of Medical Marijuana Use yourself. The in-person appointment is a one-time entry requirement, not a recurring one.
Sources
- Florida Statute § 381.986 (medical use of marijuana)
- Florida Department of Health, Office of Medical Marijuana Use (OMMU), patient registry and ID card guidance (Chapter 64-4, F.A.C.)
- National Academies of Sciences, Engineering, and Medicine (2017). The Health Effects of Cannabis and Cannabinoids.
- FDA: cannabis-derived drug approvals and cannabis regulatory status
- 18 U.S.C. § 922(g)(3) and ATF Form 4473 (firearms)
Medical cannabis is regulated under Florida Statute §381.986 and is not approved by the FDA for the treatment of any condition. The clinical evidence varies substantially by condition. Side effects and drug interactions exist and are discussed during evaluation. Cannabis remains a federally controlled Schedule I substance. This page is informational and does not substitute for a clinical visit. See Fla. Stat. § 381.986 and the Florida Department of Health, Office of Medical Marijuana Use (Chapter 64-4, F.A.C.).